U.S. FDA
Approved—for what, exactly?
These records include an FDA-approved peptide or peptide-analog product. Approval is not molecule-wide: it attaches to a reviewed product, formulation, indication, population, dose, and label.
01
Weight & Metabolism / Peptide analog
02Semaglutide
FDA approved in specific branded products and indications; compounded products are not FDA approved.
Weight & Metabolism / Peptide analog
03Tirzepatide
FDA approved in specific branded products and indications; compounded products are not FDA approved.
Growth Hormone / Peptide analog
04Tesamorelin
FDA approved only to reduce excess abdominal fat in HIV-infected adults with lipodystrophy; not indicated for weight-loss management.
Longevity / Synthetic peptide
05SS-31 / Elamipretide
FDA accelerated approval as Forzinity for Barth syndrome patients weighing at least 30 kg; other uses remain unapproved.
Sexual Health / Melanocortin receptor agonist
PT-141 / Bremelanotide
Bremelanotide is FDA approved as Vyleesi only for premenopausal women with acquired, generalized hypoactive sexual desire disorder; it is not indicated for men, postmenopausal women, or sexual performance enhancement.